Glucagon-like peptide-1 receptor agonists, which include Ozempic and Mounjaro, cost between five to 10 times more in the U.S. than other wealthy nations, according to research KFF published Aug. 17.
As of Aug. 16, about half of injectable drug solutions made by Pfizer Hospital US have little to no availability, according to a product availability report from the drugmaker.
No drug has shown to improve all-cause mortality in patients with chronic obstructive pulmonary disease — a fact that led the FDA to pen a warning letter to AstraZeneca for its advertising of its COPD drug Breztri Aerosphere.
CMS plans to soon release its list of 10 drugs that are up for price negotiations as it gears up to wield new powers granted by the Inflation Reduction Act, which passed in August 2022.
Walgreens will permanently close one of its pharmacy locations within a Maryland medical building after the retail pharmacy and owners of the medical center settled a lawsuit out of court in February, Herald Mail Media reported Aug. 15.
Researchers from Brigham and Women's Hospital in Boston have developed a probiotic to suppress autoimmunity in the brain, which is behind multiple sclerosis and several other autoimmune diseases.
Numerous hospitals and health systems have invested in drug-delivery robots for years, but recently, there's been an uptick in adopting this technology, according to Joe Burczynski, PharmD.
The FDA has granted accelerated approval to Pfizer's drug Elrexfio, which is intended to treat patients who have experienced relapsed or refractory multiple myeloma, a presently incurable type of blood cancer, according to an Aug. 14 news release.
Increasing instances of drug-resistant gonorrhea have sparked growing concerns among health experts, and now drugmakers GSK and Innoviva are inching closer to a new antibiotic solution, Bloomberg reported Aug. 10.
